The interferon/2-5A synthetase system in primary preleukaemia patients.
D015088:2',5'-Oligoadenylate Synthetase / Q000097:blood*; D004790:Enzyme Induction / Q000187:drug effects; D006680:HLA Antigens / Q000032:analysis; D006801:Humans; D066298:In Vitro Techniques; D007370:Interferon Type I / Q000494:pharmacology*; D007694:Killer Cells, Natural / Q000276:immunology; D015470:Leukemia, Myeloid, Acute / Q000201:enzymology / Q000276:immunology / Q000628:therapy; D007962:Leukocytes / Q000145:classification / Q000187:drug effects / Q000201:enzymology; D011289:Preleukemia / Q000201:enzymology* / Q000276:immunology / Q000628:therapy
D006680:HLA Antigens; D007370:Interferon Type I; D015088:2',5'-Oligoadenylate Synthetase